Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sebastian Fähndrich (Homburg/Saar, Germany), Sebastian Fähndrich, Nikolas Bernhard, Philipp M. Lepper, Claus Vogelmeier, Robert Bals. Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry. Eur Respir J 2016; 48: Suppl. 60, 4172

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Alpha-1-antitrypsin deficiency in Kazakh subjects with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Sex differences in alpha-1-antitrypsin deficiency Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Clinical, functional, radiologic and quality of life characteristics in PI*SZ Alpha 1-Antitrypsin Deficiency (AATD) compared to PI*ZZ, PI*MZ and COPD without AATD: a retrospective cohort study. Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 ALOX15 gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease (AERD) Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma Year: 2016 Bronchiectasis in patients with alpha1-antitrypsin deficiency: prevalence and characteristics Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments Year: 2016 Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 Haplotypes associated with COPD and its severity in Mexican mestizo population Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Alpha1-antitrypsin levels and phenotypes in COPD patients in Kyrgyz population Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Results from the ongoing newborn screening Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Severity of lung disease in siblings with α-1-antitrypsin deficiency (AATD) Source: Annual Congress 2008 - COPD Year: 2008 Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 The Irish national alpha-1 antitrypsin deficiency targeted detection programme Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Assessment of quality of life (SGRQ) in patients with alpha-1-antitrypsin deficiency– Analysis from the German registry Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016 Screening for alpha1-antitrypsin deficiency at a university hospital Source: International Congress 2015 – Asthma and lung immunology Year: 2015